Naveris

Waltham, MA · Founded 2017 · Privately Held (backing)

Developer of a blood test technology designed to detect specific cancer subtypes and improve patient outcomes. Naveris is based in Waltham, MA and was founded in 2017. Its last known valuation is $81.5 million. It has raised $85.5 million across 3 recorded rounds; the latest was a $17.5 million early-stage round in Jun 2024.

Last price · $/share
—
Implied valuation
$81.5M
Total raised
$85.5M
Last round
Early Stage VC
Jun 2024

Who backs Naveris?

7 investors
InvestorType
Ms2 CapitalFamily office
BrightEdgeVenture capital
ABI LAB—
American Cancer Society—
B-FLEXION Life Sciences—
TechU Ventures—
WayPoint Capital Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Naveris investors

7 investors are on record for Naveris, including Ms2 Capital, BrightEdge, ABI LAB and American Cancer Society. The early-stage round in Jun 2024 drew 5 investors.

Free account
More of Naveris with a free account
  • ·Watch Naveris: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Naveris. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View